The expression level of FTO is also elevated in cervical squamous cell carcinoma, which can enhance chemoradiotherapy resistance in vitro and in vivo by reducing m6A-regulated β-catenin expression (59). The gene discussed is FTO; the disease is cervical squamous cell carcinoma.